(Q50773376)
Statements
1 reference
Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule. (English)
1 reference
José Baselga
1 reference
Xavier Carbonell
1 reference
Noel-Jaime Castañeda-Soto
1 reference
Michael Clemens
1 reference
Michael Green
1 reference
Vernon Harvey
1 reference
Serafin Morales
1 reference
Claire Barton
1 reference
Parviz Ghahramani
1 reference
1 April 2005
1 reference
23
1 reference
2162-2171
1 reference
10
1 reference
Identifiers
1 reference